List of Contents

U.S. Virtual Care Market Size, Share, and Trends 2024 to 2034

The U.S. virtual care market size was USD 2.26 billion in 2023, calculated at USD 2.99 billion in 2024 and is projected to surpass around USD 49.68 billion by 2034, expanding at a CAGR of 32.5% from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 2419
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on US Virtual Care Market 

5.1. COVID-19 Landscape: US Virtual Care Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. US Virtual Care Market, By Application

8.1. US Virtual Care Market, by Application, 2024-2034

8.1.1. Family Medicine

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Internal Medicine

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Cardiology

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Paediatrics

8.1.4.1. Market Revenue and Forecast (2021-2034)

8.1.5. Endocrinology

8.1.5.1. Market Revenue and Forecast (2021-2034)

8.1.6. Rheumatology

8.1.6.1. Market Revenue and Forecast (2021-2034)

8.1.7. Pulmonology

8.1.7.1. Market Revenue and Forecast (2021-2034)

8.1.8. Others

8.1.8.1. Market Revenue and Forecast (2021-2034)

Chapter 9. US Virtual Care Market, By Consultation Mode

9.1. US Virtual Care Market, by Consultation Mode, 2024-2034

9.1.1. Audio

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Video

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Messaging

9.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 10. US Virtual Care Market, Regional Estimates and Trend Forecast

10.1. US

10.1.1. Market Revenue and Forecast, by Application (2021-2034)

10.1.2. Market Revenue and Forecast, by Consultation Mode (2021-2034)

Chapter 11. Company Profiles

11.1. AMD Global Telemedicine

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. CHI Health

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. ATandT

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Koninklijke Philips N.V.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. GENERAL ELECTRIC COMPANY

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Cerner Corporation

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. MDLIVE Inc

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Siemens Healthcare GmbH

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. United HealthCare Services, Inc

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. American Well

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client